Orchard Therapeutics PLC
Sairah Mohammad is a seasoned professional in the field of quality control and molecular medicine, currently serving as a QC Manager at Orchard Therapeutics since November 2020. Prior experience includes roles as a Senior QC Scientist at Autolus Ltd. and a Scientist at GSK, where Sairah developed extensive expertise in quality control processes. Earlier positions at Lonza as a Scientist and Technologist contributed to a solid foundation in scientific research and laboratory techniques. Sairah's academic background includes a Master’s degree in Molecular Medicine and Cancer Research and a Bachelor's degree in Biomedical Sciences, both obtained from Brunel University London. Additionally, Sairah gained valuable skills as a Laboratory Assistant, working on various techniques alongside a PhD student. Sairah also served as a Student Ambassador at Brunel University, providing campus tours and insights into university life.
This person is not in the org chart
Orchard Therapeutics PLC
3 followers
Orchard Therapeutics plc, formerly Orchard Rx Ltd, is a commercial-stage, fully-integrated biopharmaceutical company. It is engaged in manufacturing and commercialization of gene and cell therapies, position to provide transformative therapies to patients suffering from a range of rare diseases. The Company is focused on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders and hemoglobinopathies. Its portfolio includes Strimvelis, its commercial-stage gammaretroviral-based product for the treatment of ADA-SCID five lentiviral product candidates in clinical-stage development and several other product candidates in preclinical development. It is developing OTL-101 as an autologous ex vivo lentiviral gene therapy to sustainably treat patients with adenosine deaminase severe combined immunodeficiency (ADA-SCID) through a single administration.